Carlisle Companies to Announce 1st Quarter Results on April 27, 2017
Get Alerts CSL Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 1%
Revenue Growth %: -16.3%
Join SI Premium – FREE
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Carlisle Companies Incorporated (NYSE: CSL) will release first quarter 2017 results on Thursday, April 27, 2017 after the market closes. A conference call to discuss the quarter’s results will be held the same day at 5:00 p.m. Eastern. This conference call will be webcast live in a listen-only mode via Carlisle’s website at www.carlisle.com. The replay of the webcast will be available on the Company’s website shortly after the completion of the live call.
About Carlisle Companies
Carlisle Companies Incorporated is a global diversified company that designs, manufactures and markets a wide range of products that serve a broad range of niche markets including commercial roofing, energy, agriculture, mining, construction, aerospace and defense electronics, medical technology, foodservice, healthcare, sanitary maintenance, transportation, general industrial, protective coating, wood, specialty and auto refinishing. Through our group of decentralized operating companies led by entrepreneurial management teams, we bring innovative product solutions to solve the challenges facing our customers. Our worldwide team of employees, who generated $3.7 billion in net sales in 2016, is focused on continuously improving the value of the Carlisle brand by developing the best products, ensuring the highest quality and providing unequaled customer service in the many industries we serve. Learn more about Carlisle at www.carlisle.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170327005252/en/
Carlisle Companies Incorporated
Steven J. Ford, 480-781-5000
Vice
President of Investor Relations, Secretary and General Counsel
www.carlisle.com
Source: Carlisle Companies Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
- Denison Announces Filing of Annual Report on Form 40-F
- Doma Enters into Agreement to Go Private at Price of $6.29 Per Share in Cash; Plans to Merge with an industry leader TRG to Create Attractive Scale Opportunities
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!